Translational Research in Biomedical Sciences: Recent Progress and Future Prospects

The main objective of translational health science is to concentrate on discovering healthcare products for all people where care gaps exist. This book examines the applications of translational research, identifies its difficulties, outlines its essential characteristics, considers healthcare management strategies, and examines the public’s perspectives today. This book assists aspiring implementation scientists in researching this area because the discipline is still relatively young for the wide range of researchers tackling the challenge of clinical and translational science, a field dedicated to examining human health and disease, interventions, and outcomes to develop new treatment approaches, devices, and modalities to improve health. This book Edition is the most authoritative and timely resource that introduces new physiological and therapeutic processes to engage the fastest-growing scientific outcomes from academic and industrial research. The chapters in this book give insights into perspectives on the field of clinical and translational science and discuss artificial intelligence in drug development and conventional and novel clinical trial designs. There is a lot of hope that using artificial intelligence (AI) will significantly advance all facets of healthcare, from diagnosis to therapy. AI is prepared to assist medical staff with various duties, including administrative workflow, clinical documentation, patient outreach, and specialist support like image analysis, medical device automation, and patient monitoring. Some of the most important uses of AI in healthcare will be covered in this book by eminent Scientists, Academicians, and Industrial persons from both clinical and non-clinical fields.

Dr. Krupakar Parthasarathy, Associate Professor ( Research), is currently working at the Centre for Drug Discovery and Development, Sathyabama Institute of Science and Technology. He was trained in Infectious diseases (SARS and Dengue) drug and diagnostics development and translational research at Yong Loo Lin School of Medicine, National University of Singapore (NUS) and at Nanyang Technological University (NTU), Singapore, from 2004 to 2015. He has published more than 45 high-impact factor peer-reviewed journals, 3 International patents, 10 book chapters and developed two products. He is actively involved in translating academic research into translational applications partnering with industries. He has handled more than fifteen projects funded by national and international agencies

Dr. Radhakrishnan Manikkam, Professor (Research), is currently working at the Centre for Drug Discovery and Development, Sathyabama Institute of Science and Technology. His research focuses on Actinobacteria from different under-studied sources and environments including in the Arctic and Antarctic ocean. He has received eight research projects (4 as PI and four as Co-PI) from various central funding agencies in India for pursuing research on Actinobacteria. His more than 175 publications focus on Actinobacterial research. He has also edited a manual titled ’Protocols in Actinobacterial Research’ from the Springer Protocols Handbook series. He has published a total of 40 Book chapters.